Literature DB >> 14733905

Na(+)-D-glucose cotransporter in muscle capillaries increases glucose permeability.

Katrin Elfeber1, Frank Stümpel, Valentin Gorboulev, Sabine Mattig, Andreas Deussen, Brigitte Kaissling, Hermann Koepsell.   

Abstract

By immunohistochemistry, we demonstrated the localization of the Na(+)-D-glucose cotransporter SGLT1 in capillaries of rat heart and skeletal muscle, but not in capillaries of small intestine and submandibular gland. mRNA of SGLT1 was identified in skeletal muscle and primary cultured coronary endothelial cells. The functional relevance of SGLT1 for glucose transport across capillary walls in muscle was tested by measuring the extraction of D-glucose from the perfusate during non-recirculating perfusion of isolated rat hindlimbs. In this model, D-glucose extraction from the perfusate is increased by insulin which accelerates D-glucose uptake into myocytes by increasing the concentration of glucose transporter GLUT4 in the plasma membrane. The insulin-induced increase of D-glucose extraction from the perfusate was abolished after blocking SGLT1 with the specific inhibitor phlorizin. The data show that SGLT1 in capillaries of skeletal muscle is required for the action of insulin on D-glucose supply of myocytes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14733905     DOI: 10.1016/j.bbrc.2003.12.090

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  17 in total

1.  Expression of Na+-D-glucose cotransporter SGLT2 in rodents is kidney-specific and exhibits sex and species differences.

Authors:  Ivan Sabolic; Ivana Vrhovac; Daniela Balen Eror; Maria Gerasimova; Michael Rose; Davorka Breljak; Marija Ljubojevic; Hrvoje Brzica; Anne Sebastiani; Serge C Thal; Christoph Sauvant; Helmut Kipp; Volker Vallon; Hermann Koepsell
Journal:  Am J Physiol Cell Physiol       Date:  2012-01-18       Impact factor: 4.249

Review 2.  Direct cardiovascular impact of SGLT2 inhibitors: mechanisms and effects.

Authors:  Abdullah Kaplan; Emna Abidi; Ahmed El-Yazbi; Ali Eid; George W Booz; Fouad A Zouein
Journal:  Heart Fail Rev       Date:  2018-05       Impact factor: 4.214

3.  Empagliflozin attenuates neurodegeneration through antioxidant, anti-inflammatory, and modulation of α-synuclein and Parkin levels in rotenone-induced Parkinson's disease in rats.

Authors:  Sanaa Ahmed; Mahmoud M El-Sayed; Mohamed A Kandeil; Marwa M Khalaf
Journal:  Saudi Pharm J       Date:  2022-03-16       Impact factor: 4.562

4.  Na+-glucose cotransporter SGLT1 protein in salivary glands: potential involvement in the diabetes-induced decrease in salivary flow.

Authors:  R Sabino-Silva; H S Freitas; M L Lamers; M M Okamoto; M F Santos; U F Machado
Journal:  J Membr Biol       Date:  2009-02-24       Impact factor: 1.843

5.  A functional role for sodium-dependent glucose transport across the blood-brain barrier during oxygen glucose deprivation.

Authors:  Sharanya Vemula; Karen E Roder; Tianzhi Yang; G Jayarama Bhat; Thomas J Thekkumkara; Thomas J Abbruscato
Journal:  J Pharmacol Exp Ther       Date:  2008-11-03       Impact factor: 4.030

Review 6.  Sodium glucose cotransporter SGLT1 as a therapeutic target in diabetes mellitus.

Authors:  Panai Song; Akira Onishi; Hermann Koepsell; Volker Vallon
Journal:  Expert Opin Ther Targets       Date:  2016-04-12       Impact factor: 6.902

7.  SGLT1 is a novel cardiac glucose transporter that is perturbed in disease states.

Authors:  Sanjay K Banerjee; Kenneth R McGaffin; Núria M Pastor-Soler; Ferhaan Ahmad
Journal:  Cardiovasc Res       Date:  2009-06-09       Impact factor: 10.787

8.  Localizations of Na(+)-D-glucose cotransporters SGLT1 and SGLT2 in human kidney and of SGLT1 in human small intestine, liver, lung, and heart.

Authors:  Ivana Vrhovac; Daniela Balen Eror; Dirk Klessen; Christa Burger; Davorka Breljak; Ognjen Kraus; Nikola Radović; Stipe Jadrijević; Ivan Aleksic; Thorsten Walles; Christoph Sauvant; Ivan Sabolić; Hermann Koepsell
Journal:  Pflugers Arch       Date:  2014-10-11       Impact factor: 3.657

9.  Localization of the Na+-D-glucose cotransporter SGLT1 in the blood-brain barrier.

Authors:  Katrin Elfeber; Alwin Köhler; Michael Lutzenburg; Christina Osswald; Hans-Joachim Galla; Otto W Witte; Hermann Koepsell
Journal:  Histochem Cell Biol       Date:  2004-02-19       Impact factor: 4.304

10.  Expression of SGLT1 in Human Hearts and Impairment of Cardiac Glucose Uptake by Phlorizin during Ischemia-Reperfusion Injury in Mice.

Authors:  Yusuke Kashiwagi; Tomohisa Nagoshi; Takuya Yoshino; Toshikazu D Tanaka; Keiichi Ito; Tohru Harada; Hiroyuki Takahashi; Masahiro Ikegami; Ryuko Anzawa; Michihiro Yoshimura
Journal:  PLoS One       Date:  2015-06-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.